Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
By How Much Is The Continuous Glucose Monitor System Market Expected To Expand Between 2025 And 2029?
The continuous glucose monitoring system sector has experienced swift expansion recently, projected to increase its valuation from $8.38 billion in 2024 to $9.6 billion anticipated for 2025, reflecting a compound annual growth rate of 14.6%; this historical surge is rooted in several factors including the expanding elderly demographic, heightened consciousness surrounding diabetes treatment protocols, escalating personal disposable income levels, greater capital infusion into research endeavors, and swelling overall healthcare spending.
Anticipation points toward significant expansion within the market for continuous glucose monitoring systems over the forthcoming years, with projections indicating a valuation of $16.76 billion by 2029, fueled by a compound annual growth rate (CAGR) of 14.9%. This robust upward trajectory is largely expected due to several contributing factors, such as the escalating incidence of diabetes globally, a greater number of obesity cases, shifts in socio-economic conditions, a rise in ongoing clinical studies, and ongoing urbanization trends. Key developments anticipated to influence this market throughout the forecast duration encompass the deeper integration with smart personal devices, greater deployment of artificial intelligence (AI) technologies, the development of monitoring methods that require no skin penetration, the broader adoption of wearable health technology, and the growing reliance on telemedicine platforms and remote patient care infrastructure.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20732&type=smp
Which Drivers Are Impacting The Continuous Glucose Monitor System Market?
The escalating incidence of diabetes globally is anticipated to serve as a major catalyst for the expansion of the market for continuous glucose monitoring systems. Diabetes, a persistent health issue defined by elevated blood sugar levels stemming from the body’s insufficient insulin production or utilization, is seeing its rates climb largely due to escalating obesity levels, poor dietary habits, sedentary lifestyles, and the demographic shift towards older populations. These CGM technologies furnish immediate glucose measurements, thereby assisting in diabetes management by identifying patterns and notifying users of unusual readings, leading to enhanced glycemic control while substantially reducing the requirement for repeated fingerstick tests. As an illustration, the UK’s National Health Service reported in June 2024 that in 2023, over half a million (549,000) more people in England were found to be susceptible to developing type 2 diabetes, pushing the registered count of individuals with non-diabetic hyperglycemia, known as pre-diabetes, to 3,615,330 within GP systems; this figure is markedly higher than the 3,065,825 recorded in 2022, signifying a rise approaching 20%, which underscores why the greater occurrence of diabetes is fueling the momentum of the continuous glucose monitor system industry.
What Are The Major Segments Identified In The Continuous Glucose Monitor System Market?
The continuous glucose monitor systemmarket covered in this report is segmented –
1) By Component: Transmitters, Receivers, Sensor
2) By Technology: Real Time Continuous Glucose Monitoring, Intermittently Scanned Continuous Glucose Monitoring
3) By Demography: Child Population, Adult Population
4) By Application: Type-1 Diabetes, Type-2 Diabetes, Gestational Diabetes
5) By End-User: Diagnostics Centers, Hospitals, Clinics, Intensive Care Unit (ICUs), Home Healthcare
Subsegments:
1) By Transmitters: Bluetooth-Enabled Transmitters, Wireless Transmitters
2) By Receivers: Dedicated Devices (CGM Receiver), Smartphone-Based Receivers, Cloud-Connected Receivers
3) By Sensor: Enzyme-Based Sensors, Non-Enzyme-Based Sensors, Electrochemical Sensors
How Are Emerging Market Trends Shaping The Continuous Glucose Monitor System Industry Landscape?
Leading participants within the continuous glucose monitor system arena are directing their efforts toward innovating sophisticated, non-prescription CGMs to augment availability and broaden their customer base to include individuals not requiring a medical order. Such an over-the-counter (OTC) continuous glucose monitor (CGM) represents equipment facilitating real-time glucose level surveillance without the prerequisite of a doctor’s directive, thereby granting consumers straightforward, hassle-free entry to self-monitoring their glucose. To illustrate, Abbott Laboratories, an American medical device manufacturer, introduced its Lingo product in the United States during September 2024; this innovation is specifically tailored for adults without a diabetes diagnosis, allowing them to monitor glucose fluctuations and gain meaningful data regarding how dietary choices and physical activity correspondingly impact general wellbeing. Featuring the capacity to be worn for a maximum of two weeks, this offering bolsters Abbott’s approach to engaging the progressively expanding sector of consumers prioritizing prediabetes oversight and general health maintenance, entirely circumventing the requirement for a prescription.
Which Key Players Are Driving Competition In The Continuous Glucose Monitor System Market?
Major companies operating in the continuous glucose monitor system market are Abbott Corporation, Medtronic PLC, Murata Manufacturing Co. Ltd., Dexcom Inc., Sinocare Inc., Tandem Diabetes Care Inc., Ascensia Diabetes Care Holdings AG, Glooko Inc., DarioHealth Corp., Menarini Diagnostics SRL, Senseonics Holdings Inc., WaveForm Technologies Inc., Medtrum Technologies Inc., Biolinq Incorporated, Ultrahuman Inc., GlySens Incorporated, Glucotrack, EOFLOW CO. LTD., Nemaura Medical Inc., Meiqi Medical Equipment, Nipro Diagnostics UK Limited
Download The Full Report For Exclusive Market Findings:
Which Region Currently Holds The Largest Share Of The Continuous Glucose Monitor System Market?
North America was the largest region in the continuous glucose monitor (CGM) system market in 2024. The regions covered in the continuous glucose monitor system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Continuous Glucose Monitor System Market Report:
https://www.thebusinessresearchcompany.com/customise?id=20732&type=smp
Browse Through More Reports Similar to the Global Continuous Glucose Monitor System Market 2025, By The Business Research Company
Blood Glucose Meters Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report
Blood Glucose Test Strips Market 2025
https://www.thebusinessresearchcompany.com/report/blood-glucose-test-strips-market
Continous Blood Glucose Monitoring Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model